about
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations.Temporal changes in the pathologic assessment of prostate cancer.Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Active surveillance for prostate cancer: a review.
@ast
Active surveillance for prostate cancer: a review.
@en
Active surveillance for prostate cancer: a review.
@nl
type
label
Active surveillance for prostate cancer: a review.
@ast
Active surveillance for prostate cancer: a review.
@en
Active surveillance for prostate cancer: a review.
@nl
prefLabel
Active surveillance for prostate cancer: a review.
@ast
Active surveillance for prostate cancer: a review.
@en
Active surveillance for prostate cancer: a review.
@nl
P1476
Active surveillance for prostate cancer: a review
@en
P304
P577
2011-10-01T00:00:00Z